| Mukherjee, Pratik |
NCT04602806: Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Precision Medicine Phase 2 Option 1 |
|
|
| Completed | N/A | 50 | US | | University of California, San Francisco, U.S. Army Medical Research and Development Command | Traumatic Brain Injury | 11/22 | 01/23 | | |
| Recruiting | N/A | 65 | US | Goal-Oriented Attentional Self-Regulation (GOALS), Brain Health Education (BHE), Treatment As Usual (TAU), fMRI | VA Office of Research and Development | Brain Injuries, Traumatic | 05/25 | 12/25 | | |
| Recruiting | N/A | 2000 | US | | University of California, San Francisco, University of Washington, California Institute of Technology | Brain Disorders, Aicardi Syndrome | 01/25 | 01/25 | | |
| Manley, Geoffrey T |
APT-TBI-01, NCT05826912: Multi-Arm Multi-Stage Adaptive Platform Trial (APT) for the Acute Treatment of Traumatic Brain Injury |
|
|
| Enrolling by invitation | 2 | 672 | US | Atorvastatin Calcium, ATOR, Minocycline Hydrochloride, MINO, Candesartan Cilexetil, CAND, Placebo | University of California, San Francisco, United States Department of Defense | Traumatic Brain Injury | 08/28 | 08/29 | | |
NCT04602806: Transforming Research and Clinical Knowledge in Traumatic Brain Injury (TRACK-TBI) Precision Medicine Phase 2 Option 1 |
|
|
| Completed | N/A | 50 | US | | University of California, San Francisco, U.S. Army Medical Research and Development Command | Traumatic Brain Injury | 11/22 | 01/23 | | |
| George, Ronald B |
NCT04314544: Efficacy and Safety of Tildrakizumab Compared to Placebo in Subjects With Active Psoriatic Arthritis I (INSPIRE 1) |
|
|
| Recruiting | 3 | 472 | Europe, Canada, US, RoW | TILD, matching placebo injections | Sun Pharmaceutical Industries Limited | Active Psoriatic Arthritis | 05/25 | 02/26 | | |
NCT05881395: Assessment of Sensory Block During Labour Epidural Analgesia in Patients Experiencing Pain During First Stage of Labour. |
|
|
| Completed | N/A | 30 | Canada | | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Labor Pain | 12/23 | 12/23 | | |
NCT05946447: Intra- and Interrater Reliability of Quantitative Ultrasound Assessment of Gastric Content in Term Parturients Before Elective Caesarean Delivery |
|
|
| Completed | N/A | 30 | Canada | Ultrasound, Gastric Ultrasound | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Pregnancy, Respiratory Aspiration of Gastric Content | 10/23 | 10/23 | | |
NCT06002763: Evaluation of Patient-Reported Outcomes Measurement Information System (PROMIS)-29 v2.1 for Postpartum Women |
|
|
| Not yet recruiting | N/A | 200 | Canada | PROMIS-29 v2.1 (Patient-Reported Outcomes Measurement Information System), Patient-Reported Outcomes Measurement Information System, WHOQoLBREF (World Health Organization Quality of Life Brief Version), World Health Organization Quality of Life Brief Version, EQ-5D-3L1 (not an acronym), Global state of health numerical rating score 1-100 | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Well-Being, Psychological | 02/25 | 02/25 | | |
NCT06285409: Comparing the Dose-response Profiles of Uterotonics After Initial Carbetocin Administration - an Ex-vivo Study in Desensitized Human Myometrium |
|
|
| Recruiting | N/A | 32 | Canada | Carbetocin, Duratocin, Oxytocin, Pitocin, Ergonovine, Ergometrine, Carboprost, Hemabate | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Postpartum Hemorrhage | 10/24 | 10/24 | | |
NCT06333340: Comparative Efficacy of Carbetocin and Oxytocin in Parturients at Risk of Atonic Postpartum Hemorrhage Undergoing Elective Cesarean Delivery |
|
|
| Recruiting | N/A | 160 | Canada | Oxytocin, Pitocin, Carbetocin, Duratocin | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Post Partum Hemorrhage | 12/25 | 12/25 | | |
NCT06572241: Quality of Labour Epidural Analgesia With Intrathecal Morphine as a Component of Combined Spinal Epidural |
|
|
| Recruiting | N/A | 182 | Canada | Intrathecal morphine, Morphine, Saline solution (placebo), saline | Samuel Lunenfeld Research Institute, Mount Sinai Hospital | Labor Pain | 09/25 | 09/25 | | |
| Mitchell, Jennifer |
| Recruiting | 3 | 200 | US | Placebo, MM120 (LSD D-Tartrate) | Mind Medicine, Inc. | Generalized Anxiety Disorder | 05/26 | 11/26 | | |
SnS, NCT06626139: Investigating the Interaction of Psilocybin and Context of Its Administration in Healthy Volunteers |
|
|
| Recruiting | 2 | 120 | US | Psilocybin, Context 1, Context 2, Placebo | Robin Carhart-Harris, PhD, MA | Healthy Participants with Lower-than-average Mental Well-being | 11/27 | 11/28 | | |
| Completed | N/A | 186 | Canada, US, RoW | | Lykos Therapeutics | PTSD | 05/24 | 05/24 | | |
WB, NCT05963607: RCT of a Weighted Blanket to Reduce Pain in Veterans With Chronic Pain |
|
|
| Recruiting | N/A | 160 | US | Weighted blanket | VA Office of Research and Development | Chronic Pain, Sleep Disturbance | 04/29 | 09/29 | | |
| Wais, Peter E |
| Recruiting | N/A | 200 | US | LabyrinthVR software, Placebo Games software, Labyrinth Tablet software, Labyrinth VR wireless | University of California, San Francisco | Long-Term Memory Decline, Mild Cognitive Impairment | 12/26 | 01/27 | | |
| Arioli, Melissa |
| Recruiting | N/A | 200 | US | LabyrinthVR software, Placebo Games software, Labyrinth Tablet software, Labyrinth VR wireless | University of California, San Francisco | Long-Term Memory Decline, Mild Cognitive Impairment | 12/26 | 01/27 | | |
| Tan, Lisa |
| Recruiting | 3 | 560 | Europe, Canada, Japan, US, RoW | sigvotatug vedotin, SGN-B6A; PF-08046047, docetaxel | Seagen Inc. | Carcinoma, Non-Small-Cell Lung | 07/26 | 07/28 | | |
PRECISION 1, NCT05103358: Phase 2 Basket Trial of Nab-sirolimus in Patients With Malignant Solid Tumors With Pathogenic Alterations in TSC1/TSC2 Genes |
|
|
| Active, not recruiting | 2 | 120 | US, RoW | nab-sirolimus, ABI-009 | Aadi Bioscience, Inc. | Tumor, Tumor, Solid, Metastasis, Metastatic Cancer, Cancer, Cancer Metastatic, Tumors, Neoplasms, Neoplasm Metastasis, Solid Tumor, Advanced Solid Tumor, Advanced Cancer, Malignant Solid Tumor, Malignant Solid Neoplasm, Malignant Neoplasm, Malignant Tumor, TSC, TSC1, TSC2, Metastatic Solid Tumor, Metastatic Neoplasm | 12/24 | 12/25 | | |
NCT06217536: Neoadjuvant Lurbinectedin and Preoperative Radiation for Treating Soft Tissue Sarcomas |
|
|
| Withdrawn | 1/2 | 70 | NA | Lurbinectedin, Zepzelca, Radiotherapy, Radiation therapy, Non-investigational surgery | University of California, San Francisco, Jazz Pharmaceuticals | Locally Advanced Soft Tissue Sarcoma | 05/26 | 10/27 | | |
| Recruiting | 1 | 38 | US | Osimertinib, Tagrisso, Alisertib, MLN8237 | Collin Blakely, Puma Biotechnology, Inc. | Lung Cancer Metastatic, EGFR Gene Mutation | 12/26 | 12/26 | | |
NCT05435846: Capmatinib Plus Trametinib for the Treatment of Metastatic Non-small Cell Lung Cancer With MET Exon 14 Skipping Mutation |
|
|
| Terminated | 1 | 3 | US | Capmatinib, INC280, Trametinib, TMT212, Mekinist | Collin Blakely, Novartis | Metastatic Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer | 11/23 | 05/24 | | |
| Carhart-Harris, Robin |
SnS, NCT06626139: Investigating the Interaction of Psilocybin and Context of Its Administration in Healthy Volunteers |
|
|
| Recruiting | 2 | 120 | US | Psilocybin, Context 1, Context 2, Placebo | Robin Carhart-Harris, PhD, MA | Healthy Participants with Lower-than-average Mental Well-being | 11/27 | 11/28 | | |
| Recruiting | 1 | 12 | NA | Psilocybin | Robin Carhart-Harris, PhD, MA | Psychedelic Experiences, Neuroimaging, Healthy Volunteers | 11/25 | 11/25 | | |
| Allison, Kate |
SnS, NCT06626139: Investigating the Interaction of Psilocybin and Context of Its Administration in Healthy Volunteers |
|
|
| Recruiting | 2 | 120 | US | Psilocybin, Context 1, Context 2, Placebo | Robin Carhart-Harris, PhD, MA | Healthy Participants with Lower-than-average Mental Well-being | 11/27 | 11/28 | | |
